Eric H Kuhrts

Eric is the founder and CEO of five pharmaceutical companies, and is the inventor of over 30 issued and pending patent applications. Eric has developed and licensed novel proprietary diagnostic biomarkers, major sports supplement products, numerous over-the counter (OTC) drug products, drug delivery systems, and many new biopharmaceutical formulations in the cardiovascular, and anti-inflammatory area. Eric also has extensive experience in the development of new drugs that require FDA approval via new drug application (IND/NDA) submissions. Eric is a graduate of the University of California at San Diego.

( Bio Updated from Original Bio posted on Bionovix management page )

According to Cory Carter from Bionovix Eric Kuhrts bio has been changed. We have posted the new bio, but the original as posted remains archived here as part of our efforts to maintain true and correct information for consumers using our site )

Eric is the founder and CEO of five pharmaceutical companies, and is the inventor of over 30 issued and pending patent applications. He has been involved in numerous aspects of management and research related to pharmaceuticals, diagnostics, and consumer products for over 18 years. One of his inventions, the Bios® Life2 generated over $180 million dollars in annual revenues (close to $2 billion in sales over a 10 year period) for the Rexall Sundown company’s Rexall Showcase International network marketing division, and paid millions in royalties before being sold for a substantial projected royalty stream. Eric has developed and licensed novel proprietary diagnostic biomarkers, major sports supplement products, numerous over-the counter (OTC) drug products, drug delivery systems, and many new biopharmaceutical formulations in the cardiovascular, and anti-inflammatory area. Eric also has extensive experience in the development of new drugs that require FDA approval via new drug application (IND/NDA) submissions. Eric is a graduate of the University of California at San Diego.